"The groundwork of all happiness is health." - Leigh Hunt

Bacterial epidemic linked to EzriCare eye drops: CDC

Editor's note: This story was updated on February 3 with details in regards to the recall.

February 1, 2023 – A bacterial outbreak linked to eye drops has caused one death and sickened at the least 55 people in 11 states, in response to the CDC. Some patients have been hospitalized and a few at the moment are permanently blind. At least one person has died from a blood infection linked to the drops.

“Recent epidemiological and laboratory evidence links these infections to the use of EzriCare artificial tears,” the CDC said in a opinion.

Although no recall was initially requested, Global Pharma Healthcare, the manufacturer of the products, announced Thursday that it was recalling all artificial tear drops sold within the United States.

The CDC recommends stopping the usage of EzriCare artificial tears. The over-the-counter product is on the market at retailers equivalent to Walmart.

The bacteria, Pseudomonas aeruginosatypically causes blood or lung infections which can be immune to many antibiotics. The sort of bacteria is present within the environment and is usually present in water and soil.

The cases occurred from May 17, 2022, to January 19, in the next states: California, Colorado, Connecticut, Florida, New Jersey, New Mexico, New York, Nevada, Texas, Utah and Washington.

New Jersey-based company EzriCare released a special website and stated that the corporate has not received any complaints from consumers on this regard.

In an announcement on its website on Jan. 24, the corporate said it had “not received any communication from any regulatory agency providing EzriCare with findings or details of the ongoing investigation. We have not been asked to conduct a recall.”

The CDC said its investigation continues to be ongoing.